| scholarly article | Q13442814 |
| P50 | author | Sorin Hostiuc | Q51700122 |
| P2093 | author name string | Mihai Marinescu | |
| Paula Perlea | |||
| Eduard Drima | |||
| Catalin Dogaroiu | |||
| P2860 | cites work | Glycogen synthase kinase-3β inhibition attenuates the degree of arthritis caused by type II collagen in the mouse | Q62107805 |
| Thalidomide has 37-year history | Q68932078 | ||
| Threonine 41 in beta-catenin serves as a key phosphorylation relay residue in beta-catenin degradation | Q83160998 | ||
| Patient and parent understanding of informed consent in orthodontics | Q40550075 | ||
| Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling | Q42032355 | ||
| Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3beta and attenuated by lithium | Q43786473 | ||
| Glycogen synthase kinase-3β antagonizes ROS-induced hepatocellular carcinoma cell death through suppression of the apoptosis signal-regulating kinase 1. | Q46542965 | ||
| An emerging role for Wnt and GSK3 signaling pathways in schizophrenia | Q46956051 | ||
| A survey of language barriers from the perspective of pediatric oncologists, interpreters, and parents | Q47211823 | ||
| Role of glycogen synthase kinase-3beta in early depressive behavior induced by mild traumatic brain injury. | Q48278662 | ||
| Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase | Q48406074 | ||
| Cytoplasmic accumulation of glycogen synthase kinase-3beta is associated with aggressive clinicopathological features in human prostate cancer | Q48597114 | ||
| A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy. | Q50479057 | ||
| IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. | Q54600671 | ||
| Lay understanding of terms used in cancer consultations | Q56555298 | ||
| Glycogen Synthase Kinase-3β Inhibition Attenuates Asthma in Mice | Q58620305 | ||
| A molecular mechanism for the effect of lithium on development | Q24629067 | ||
| Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics | Q24685475 | ||
| Translational research-the need of a new bioethics approach | Q28069484 | ||
| Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor | Q29614622 | ||
| Glycogen synthase kinase-3 in the etiology and treatment of mood disorders | Q30474415 | ||
| Glycogen synthase kinase 3: a key regulator of cellular fate. | Q33285838 | ||
| A new avenue for lithium: intervention in traumatic brain injury | Q33777980 | ||
| Communication, decision making, and cancer: what African Americans want physicians to know | Q34138433 | ||
| Preclinical and clinical investigations of mood stabilizers for Huntington's disease: what have we learned? | Q34284039 | ||
| Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot study. | Q34296827 | ||
| GSK-3 inhibitor inhibits cell proliferation and induces apoptosis in human osteosarcoma cells | Q34675282 | ||
| Babel babble: physicians' use of unclarified medical jargon with patients | Q34700317 | ||
| GSK-3 modulates cellular responses to a broad spectrum of kinase inhibitors | Q34735363 | ||
| GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke | Q35154467 | ||
| Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expression | Q36019650 | ||
| Teratogenic and developmental effects of lithium | Q36447380 | ||
| A method to quantify residents' jargon use during counseling of standardized patients about cancer screening. | Q37000434 | ||
| The GSK3 hypothesis of Alzheimer's disease | Q37035378 | ||
| Lithium prevents and ameliorates experimental autoimmune encephalomyelitis | Q37245952 | ||
| The role of glycogen synthase kinase-3β (GSK-3β) in endometrial carcinoma: A carcinogenesis, progression, prognosis, and target therapy marker | Q37317321 | ||
| GSK-3 inhibitors and insulin receptor signaling in health, disease, and therapeutics | Q37410145 | ||
| Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice | Q37417156 | ||
| Phosphorylation of neuronal survival factor MEF2D by glycogen synthase kinase 3beta in neuronal apoptosis | Q37432069 | ||
| The effects of brain serotonin deficiency on behavioural disinhibition and anxiety-like behaviour following mild early life stress | Q37596243 | ||
| GSK-3β, a pivotal kinase in Alzheimer disease. | Q38218085 | ||
| Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases | Q38272835 | ||
| Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3beta. | Q38756671 | ||
| Hypoxic inactivation of glycogen synthase kinase-3β promotes gastric tumor growth and angiogenesis by facilitating hypoxia-inducible factor-1 signaling | Q38760550 | ||
| Promotion of natural tooth repair by small molecule GSK3 antagonists | Q39032328 | ||
| Incomplete and inconsistent information provided to men making decisions for treatment of early-stage prostate cancer | Q39136691 | ||
| ShRNA silencing glycogen synthase kinase-3 beta inhibits tumor growth and angiogenesis in pancreatic cancer | Q39440430 | ||
| A short history of thalidomide embryopathy | Q39562228 | ||
| Glycogen synthase kinase 3 inhibitors in the next horizon for Alzheimer's disease treatment | Q39728463 | ||
| Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer. | Q40134202 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ethical analysis | Q98139384 |
| P304 | page(s) | 1495 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | GSK-3 Inhibitors and Tooth Repair: An Ethical Analysis | |
| P478 | volume | 9 |
Search more.